ArticleBritish journal of cancer2013

Peroxiredoxin-3 is overexpressed in prostate cancer and promotes cancer cell survival by protecting cells from oxidative stress.

H C Whitaker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.